Tested Applications
| Positive WB detected in | mouse liver tissue, HepG2 cells, human liver tissue, rat liver tissue |
| Positive IP detected in | mouse liver tissue, HepG2 cells |
| Positive IHC detected in | human liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
15681-1-AP targets KHK in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag8182 Product name: Recombinant human KHK protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-298 aa of BC006233 Sequence: MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTILSLLGAPCAFMGSMAPGHVADFVLDDLRRYSVDLRYTVFQTTGSVPIATVIINEASGSRTILYYDRSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV Predict reactive species |
| Full Name | ketohexokinase (fructokinase) |
| Calculated Molecular Weight | 298 aa, 33 kDa |
| Observed Molecular Weight | 33-35 kDa |
| GenBank Accession Number | BC006233 |
| Gene Symbol | KHK |
| Gene ID (NCBI) | 3795 |
| RRID | AB_2130496 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P50053 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Ketohexokinase catalyzes conversion of fructose to fructose-1-phosphate, it is the first enzyme with a specialized pathway that catabolizes dietary fructose. Fructose metabolism seems to provide cancer cells with the supplementary fuel required for proliferation and metastasis.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for KHK antibody 15681-1-AP | Download protocol |
| IHC protocol for KHK antibody 15681-1-AP | Download protocol |
| IP protocol for KHK antibody 15681-1-AP | Download protocol |
| WB protocol for KHK antibody 15681-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The KHK Polyclonal antibody (Cat# 15681-1-AP) has 15 citations across 14 journals, including Signal Transduction and Targeted Therapy, Cell Metabolism, Nature Metabolism, Advanced Science, Brain, FASEB Journal, Cancer Science, and Biochemical and Biophysical Research Communications. Research fields span fructose metabolism, hepatocellular carcinoma, cervical cancer, pancreatic cancer, glioma, breast cancer, ALS, hyperuricemia, glucose homeostasis, and cardiac hypertrophy. Applications are predominantly Western blot, with some IHC and IF.
| Species | Application | Title |
|---|---|---|
Signal Transduct Target Ther Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis | ||
Cell Metab High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate | ||
Adv Sci (Weinh) NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer | ||
Brain C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. | ||
Eur J Pharmacol Oxyberberine alleviates fructose-induced hyperuricemia by modulating purine metabolism and gut microbiota |

























